Business
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
SAN FRANCISCO, February 23, 2026--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com.
About this update from Hims & Hers Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2562,"height":408,"url":"https://media.zenfs.com/en/business-wire.com/31f75bef242797b54a51a8ddaa88e030"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QLV48Qolp0Bgwk8sAmANJA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1MztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/31f75bef242797b54a51a8ddaa88e030","width":960,"height":153},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/_7PdnFkxBC2a0PSGWAEHmg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zODI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/31f75bef242797b54a51a8ddaa88e030","width":1200,"height":191}},"lazy":false},{"type":"text","content":"Revenue of approximately $2.35 billion, up 59% year-over-year in 2025","length":69,"tagName":"p","attribs":{}},{"type":"text","content":"Net income of $128 million; Adjusted EBITDA of $318 million in 2025","length":67,"tagName":"p","attribs":{}},{"type":"text","content":"Subscribers grew to over 2.5 million, up 13% year-over-year in 2025","length":67,"tagName":"p","attribs":{}},{"type":"text","content":"Provides Q1 and full year 2026 guidance1, with full year 2026 revenue in the range of $2.7 billion to $2.9 billion and Adjusted EBITDA in the range of $300 million to $375 million","length":179,"tagName":"p","attribs":{}},{"type":"text","content":"SAN FRANCISCO, February 23, 2026--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com.","length":348,"tagName":"p"},{"type":"text","content":""More than 2.5 million subscribers now rely on us for a healthcare experience that is both accessible and deeply personal – and we believe we’re well on our way to becoming the global leader in consumer health," said Andrew Dudum, co-founder and CEO. "In 2025, we made it possible for more customers across the world to depend on us for access to care across an expanding range of conditions. From launching hormone therapies and diagnostics, introducing Labs to unlock deeper health insights, and taking meaningful steps to grow internationally, the i...